Formula and pharmaceutical preparation for treating foot ulcer and application method of pharmaceutical preparation

Abstract

The invention relates to a formula and pharmaceutical preparation for treating foot ulcer and an application method of the pharmaceutical preparation. The formula for treating foot ulcer comprises thefollowing substances in parts by weight of 2-3 parts of trachelospermum jasminoides, 5-6 parts of intermediary magnoliavine herbs, 1-2 parts of ligusticum wallichii, and 2-3 parts of dried stems of ski mmia arborescens t.anders ex gamble. The invention further provides a pharmaceutical preparation and an application method. The pharmaceutical preparation has the following advantages of being reasonable in formula compatibility, has the function of relieving pain, contains bone formation protein-1(BMP1) recombination protein and reorganization human bone shape generation protein-2(BMP2) replace protein, and achieves fundamental physiology repair on ulcer feet. The pharmaceutical preparation can enable efficacy of effective components of medicinal materials to be high, the needed time is short, the wine preparation efficacy is good, and the pharmaceutical preparation has the effects of sterilization and disinfection on damaged and affected parts. The application method can be taken orally and externally applied, and when the pharmaceutical preparation is taken orally and externally applied at the same time, good treatment effects can be obtained.

Description

technical field [0001] The invention relates to a pharmaceutical preparation, mainly aimed at diabetic ulcer foot and vasculitis ulcer foot, in particular to a prescription for treating ulcer foot, a pharmaceutical preparation and an application method thereof. Background technique [0002] Diabetic foot is one of the most serious complications of diabetic patients due to lower extremity infection, ulcer formation and / or destruction of deep tissues due to neuropathy and peripheral vascular disease. Among them, diabetic foot ulcers are the main cause of lower limb amputation in diabetic patients. Studies have shown that diabetic foot accounts for 12.4% of hospitalized diabetic patients, and the amputation rate is 7.3%. More than 15% of people with diabetes will develop foot ulcers in their lifetime. Between 14% and 24% of patients with foot ulcers require amputation. [0003] Thromboangiitis obliterans is a rare chronic relapsing segmental inflammatory disease of medium and...

AI Technical Summary

Problems solved by technology

[0004] The above-mentioned diabetic ulcer foot and vasculitis ulcer foot are difficult diseases that cannot be repaired physiologically at home and abroad at present, and the cause has not been identified, and there is no relevant diagnostic technical plan and corresponding technical plan